We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
66 hedge funds and large institutions have $40M invested in Cardiff Oncology in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
16% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 19
0% more funds holding
Funds holding: 66 → 66 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
5% less capital invested
Capital invested by funds: $42.3M → $40M (-$2.27M)
91% less call options, than puts
Call options by funds: $60K | Put options by funds: $689K
Holders
66
Holders Change
–
Holders Change %
0%
% of All Funds
1.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
22
Reduced
19
Closed
7
Calls
$60K
Puts
$689K
Net Calls
-$629K
Net Calls Change
-$1.01M
Top Buyers
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$1.75M |
| 2 |
Goldman Sachs
New York
|
-$376K |
| 3 |
TCIM
TIAA CREF Investment Management
New York
|
-$260K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$119K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$96.2K |
